or Try an Advanced Search...

    Technical Analysis for ATYR - aTyr Pharma, Inc.

    Grade Last Price % Change Price Change
    C 2.94 -1.67% -0.05
    ATYR closed down 1.64 percent on Wednesday, November 20, 2024, on 54 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical ATYR trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction -1.67%
    NR7-2 Range Contraction -1.67%
    Inside Day Range Contraction -1.67%
    Oversold Stochastic Weakness -1.67%
    Spinning Top Other -3.29%
    NR7 Range Contraction -3.29%
    Stochastic Reached Oversold Weakness -3.29%
    Oversold Stochastic Weakness -3.29%
    1,2,3 Pullback Bullish Bullish Swing Setup -2.33%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.33%
    Older End-of-Day Signals for ATYR ...

       Recent Intraday Alerts

    Alert Time
    Up 1% about 1 hour ago
    60 Minute Opening Range Breakout about 2 hours ago
    Down 3% about 4 hours ago
    Fell Below Previous Day's Low about 4 hours ago
    Down 2 % about 4 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ATYR Chart by TradingView
    Basic chart:

    Profile

    aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology

    Is ATYR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis
    Nov 7 aTyr Pharma GAAP EPS of -$0.23 misses by $0.01
    Nov 7 aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update
    Oct 24 aTyr Pharma: The Bull Has Finally Come Out
    Oct 24 High Growth Tech Stocks to Watch in October 2024
    Oct 14 aTyr Pharma to Present at the LD Micro Main Event XVII in October
    Oct 8 aTyr Pharma’s Lead Therapeutic Candidate Efzofitimod for Pulmonary Sarcoidosis to be Featured in Best of CHEST Journals at CHEST 2024 Annual Meeting
    Oct 2 aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal
    Sep 9 aTyr Pharma: Two 2025 Data Readouts Could Provide Inflection Point
    Sep 5 aTyr started at buy by Jefferies, citing efzofitimod potential
    See more ATYR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.8001
    52 Week Low 1.14
    Average Volume 959,015
    200-Day Moving Average 1.99
    50-Day Moving Average 2.56
    20-Day Moving Average 3.18
    10-Day Moving Average 3.17
    Average True Range 0.24
    RSI (14) 50.25
    ADX 35.67
    +DI 27.26
    -DI 24.24
    Chandelier Exit (Long, 3 ATRs) 3.07
    Chandelier Exit (Short, 3 ATRs) 3.54
    Upper Bollinger Bands 3.50
    Lower Bollinger Band 2.86
    Percent B (%b) 0.2
    BandWidth 19.92
    MACD Line 0.12
    MACD Signal Line 0.20
    MACD Histogram -0.0755
    Fundamentals Value
    Market Cap 175.09 Million
    Num Shares 58.6 Million
    EPS -0.95
    Price-to-Earnings (P/E) Ratio -3.15
    Price-to-Sales 10.89
    Price-to-Book 1.17
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.23
    Resistance 3 (R3) 3.24 3.16 3.19
    Resistance 2 (R2) 3.16 3.10 3.16 3.18
    Resistance 1 (R1) 3.08 3.06 3.04 3.07 3.16
    Pivot Point 3.00 3.00 2.99 3.00 3.00
    Support 1 (S1) 2.92 2.94 2.88 2.91 2.82
    Support 2 (S2) 2.84 2.90 2.84 2.80
    Support 3 (S3) 2.76 2.84 2.79
    Support 4 (S4) 2.75